Cargando…
HDL Improves Cholesterol and Glucose Homeostasis and Reduces Atherosclerosis in Diabetes-Associated Atherosclerosis
BACKGROUND AND AIMS: Apolipoprotein A-I (ApoA-I), the main component of high-density lipoprotein (HDL), not only promotes reverse cholesterol transport (RCT) in atherosclerosis but also increases insulin secretion in pancreatic β-cells, suggesting that interventions which raise HDL levels may be ben...
Autores principales: | Di Bartolo, Belinda A., Cartland, Siân P., Genner, Scott, Manuneedhi Cholan, Pradeep, Vellozzi, Melissa, Rye, Kerry-Anne, Kavurma, Mary M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8163542/ https://www.ncbi.nlm.nih.gov/pubmed/34095317 http://dx.doi.org/10.1155/2021/6668506 |
Ejemplares similares
-
NADPH Oxidases, Angiogenesis, and Peripheral Artery Disease
por: Manuneedhi Cholan, Pradeep, et al.
Publicado: (2017) -
TRAIL-Expressing Monocyte/Macrophages Are Critical for Reducing Inflammation and Atherosclerosis
por: Cartland, Siân P., et al.
Publicado: (2019) -
TRAIL-Deficiency Accelerates Vascular Calcification in Atherosclerosis via Modulation of RANKL
por: Di Bartolo, Belinda A., et al.
Publicado: (2013) -
Correction: TRAIL-Deficiency Accelerates Vascular Calcification in Atherosclerosis via Modulation of RANKL
por: Di Bartolo, Belinda A., et al.
Publicado: (2013) -
Non-alcoholic fatty liver disease, vascular inflammation and insulin resistance are exacerbated by TRAIL deletion in mice
por: Cartland, Siân P., et al.
Publicado: (2017)